Skip to main content
SpringerLink
Log in

Clinical aspects of the melatonin action: impact of development, aging, and puberty, involvement of melatonin in psychiatric disease and importance of neuroimmunoendocrine interactions

  • Multi-Author Reviews
  • Melatonin and the Light-Dark Zeitgeber in Vertebrates, Invertebrates and Unicellular Organisms
  • Published:
Experientia Aims and scope Submit manuscript

Abstract

During the last decade we have learned much on physiological changes in the secretion of the pineal hormone melatonin (MLT) in man. Reportedly, there is little or no MLT secreted before age 3 months. Then MLT production commences, becmes circadian, and reaches highest nocturnal levels at the age of 1–3 years. During all of childhood nocturnal peak levles drop progressively by 80% until adult levels are reached. This alteration appears to be the consequence of increasing body size in face of constant MLT production during childhood. The biological significance of this MLT alteration is presently unknown. Because of conceptual considerations, major depressive syndrome (MDS) and seasonal affective disorder (SAD) have been in the focus of pineal research for several years. Although in these disorders alterations in MLT levels could not be substantiated, light therapy, a consequence of this research, was discovered as an effective treatment for SAD and perhaps for MDS. In addition, there is some recent evidence for low MLT levels in schizophrenia. Finally, the potential effect of MLT in neuroimmunoendocrine interactions is presently explored. Reportedly, in vitro studies and animal experiments give evidence for a modulatory role of MLT in the immune response. However, the exact way of this possible action of MLT remains to be clarified. Clinical studies are too scant for a meaningful estimation of MLT's involvement in human neuroimmunoendocrine interactions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Abo, T., Kawate, T., Itoh, K., and Kumagai, K., Studies on the bioperiodicity of the immune response: I. Circadian rhythms of human T, B, and K cell traffic in the peripheral blood. J. Immun.126 (1981) 1360–1363.

    PubMed  Google Scholar 

  2. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders. 3rd Ed. American psychiatric press Inc., Washington, D. C. 1980.

    Google Scholar 

  3. Arendt, J., Melatonin. Clin. Endocr. (Oxford)29 (1988) 205–229.

    Google Scholar 

  4. Arendt, J., Melatonin: a new probe in psychiatric investigation. Br. J. Psychiatry155 (1989) 585–590.

    PubMed  Google Scholar 

  5. Arendt, J., Hampton, S., English, J., Kwasowski, P., and Marks, V., 24-hour profiles of melatonin, cortisol, insulin, C-peptide and GIP following a meal and subsequent fasting. Clin. Endocr. (Oxford)16 (1982) 89–95.

    Google Scholar 

  6. Arendt, J., Labib, M. H., Bojkowski, C., Hanson, S., and Marks, V., Rapid decrease in melatonin, production during successful treatment of delayed puberty [letter]. Lancet1 (1989) 1326–1326.

    Google Scholar 

  7. Armstrong, S. M., Melatonin and circadian control in mammals. Experientia45 (1989) 932–938.

    PubMed  Google Scholar 

  8. Attanasio, A., Borrelli, P. and Gupta, D., Circadian rhythms in serum melatonin from infancy to adolescence. J. clin. Endocr. Metab.61 (1985) 388–390.

    PubMed  Google Scholar 

  9. Attanasio, A., Rager, K., and Gupta, D., Ontogeny of circadian rhythmicity for melatonin, serotonin, and N-acetylserotonin in humans. J. Pineal Res.3 (1986) 251–256.

    PubMed  Google Scholar 

  10. Austen, F. K., and Humphrey, J. H., In vitro studies of the mechanisms of anaphylasix. Adv. Immun.3 (1963) 1–4.

    Google Scholar 

  11. Bartsch, C., Bartsch, H., Fluchter, S. H., and Lippert, T. H., Depleted pineal melatonin production in patients with primary breast and prostate cancer is connected with circadian disturbances of central hormones: possible role of melatonin for maintenance and synchronization of circadian rhythmicity, in: Melatonin and the Pineal Gland — From Basic Science to Clinical Application, pp. 311–316. Eds Y. Touitou, J. Arendt, and P. Pevet, Elsevier Science Publishers B. V., Amsterdam 1993.

    Google Scholar 

  12. Bartsch, C., Bartsch, H., and Lippert, T. H., Bedeutung der Zirbeldruese bei Reproduktion und gynaekologischen Tumoren (Role of the pineal body in reproduction and in gynecologic tumors). Geburtsh. Frauenheilk.51 (1991) 1–8.

    PubMed  Google Scholar 

  13. Beck Friis, J., Kjellman, B. F., Aperia, B., Unden, F., von Rosen, D., Ljunggren, J. G., and Wetterberg, L. Serum melatonin in relation to clinical variables in patients with major depressive disorder and a hypothesis of a low melatonin syndrome. Acta psychiat. scand.71 (1985) 319–330.

    PubMed  Google Scholar 

  14. Beck Friis, J., Ljunggren, J. G., Thoren, M., von Rosen, D., Kjellman, B. F., and Wetterberg, L. Melatonin, cortisol and ACTH in patients with major depressive disorder and healthy humans with special reference to the outcome of the dexamethasone suppression test. Psychoneuroendocrinology10 (1985) 173–186.

    PubMed  Google Scholar 

  15. Beck Friis, J., von Rosen, D., Kjellman, B. F., Ljunggren, J. G., and Wetterberg, L., Melatonin in relation to body measures, sex, age, season and the use of drugs in patients with major affective disorders and healthy subjects. Psychoneuroendocrinology9 (1984) 261–277.

    PubMed  Google Scholar 

  16. Berga, S. L., Jones, K. L., Kaufmann, S., and Yen, S. S., Nocturnal melatonin levels are unaltered by ovarian suppresion in girls with central precocious puberty. Fert. Steril.52 (1989) 936–941.

    Google Scholar 

  17. Besedovsky, H. O., Del Rey, A. E., and Sorkin, E., Immuneneuroendocrine interactions. J. Immun.135 (1985) 750s-754s.

    PubMed  Google Scholar 

  18. Birau, N., Maternal serum melatonin during normal pregnancy. IRCS Med. Sci.12 (1984) 455–455.

    Google Scholar 

  19. Blalock, J. E., The immune system as a sensory organ. J. Immun.132 (1984) 1067–1070.

    PubMed  Google Scholar 

  20. Blask, D. E., The pineal: an oncostatic gland? in: The Pineal Gland, pp. 253–284. Ed. R. J. Reiter. Raven Press, New York 1984.

    Google Scholar 

  21. Blask, D. E., Hill, S. M., Orstead, K. M., and Massa, J. S., Inhibitory effects of the pineal hormone melatonin and underfeeding during the promotional phase of 7,12-dimethyl-benzanthracene-(DMBA)-induced mammary tumorigenesis. J. Neural. Transm.67 (1986) 125–138.

    PubMed  Google Scholar 

  22. Blask, D. E., Lemus-Wilson, A. M., Wilson, S. T., and Cos, S., Neurohormonal modulation of cancer growth by pineal melatonin, in: Melatonin and the Pineal Gland — From Basic Science to Clinical Application, pp. 303–310. Eds Y. Touitou, J. Arendt, and P. Pevet. Elsevier Science Publishers B. V., Amsterdam 1993.

    Google Scholar 

  23. Blazquez, E., Lopez Gil, A., Alvarez, E., and Munoz Barragan, L., Biochemical and ultrastructural approaches to the onset of the pineal melatonin rhythm in the rat. Neuroendocrinology50 (1989) 500–505.

    PubMed  Google Scholar 

  24. Blehar, M. C., and Rosenthal, N. E., Seasonal affective disorders and phototherapy. Report of a National Institute of Mental Health-sponsored workshop. Archs gen. Psychiat.46 (1989) 469–474.

    Google Scholar 

  25. Bojkowski, C. J., and Arendt, J., Factors influencing urinary 6-sulphatoxymelatonin, a major melatonin metabolite, in normal human subjects. Clin. Endocr. (Oxford)33 (1990) 435–444.

    Google Scholar 

  26. Brown, G. M., Young, S. N., Gauthier, S., Tsui, H., and Grota, L. J., Melatonin in human cerebrospinal fluid in daytime; its origin and variation with age. Life Sci.25 (1979) 929–936.

    PubMed  Google Scholar 

  27. Brown, R., Kocsis, J. H., Caroff, F., Amsterdam, J., Winokur, A., Stokes, P. E., and Frazer, A., Differences in nocturnal melatonin secretion between melancholic depressed patients and control subjects. Am. J. Psychiat.,142 (1985) 811–816.

    PubMed  Google Scholar 

  28. Cardinali, D. P., Melatonin. I. A mammalian pineal hormone. Endocr. Rev.2 (1981) 327–346.

    PubMed  Google Scholar 

  29. Cavallo, A., Plasma melatonin rhythm in normal puberty: interactions of age and pubertal stages. Neuroendocrinology55 (1992) 372–379.

    PubMed  Google Scholar 

  30. Cavallo, A., Holt, K. G., Hejazi, M. S., Richards, G. E., and Meyer, W., J. 3d. Melatonin circadian rhythm in childhood depression. J. Am. Acad. Child. Adolesc. Psychiat.26 (1987) 395–399.

    Google Scholar 

  31. Checkley, S., Monoamines, depression and antidepressent drugs. Pharmacopsychiatry21 (1988) 6–8.

    PubMed  Google Scholar 

  32. Claustrat, B., Chazot, G., Brun, J., Jordan, D., and Sassolas, G., A chronobiological study of melatonin and cortisol secretion in depressed subjects: plasma melatonin, a biochemical marker in major depression. Biol. Psychiatry19 (1984) 1215–1228.

    PubMed  Google Scholar 

  33. Cohen, H. N., Hay, I. D., Annesley, T. M., Beastall, G. H., Wallace, A. M., Spooner, R., Thomson, J. A., Eastwold, P., and Klee, G. G., Serum immunoreactive melatonin in boys with delayed puberty. Clin. Endocr. (Oxford)17 (1982) 517–521.

    Google Scholar 

  34. Ehrenkranz, J. R., Tamarkin, L., Comite, F., Johnsonbaugh, R. E., Bybee, D. E., Loriaux, D. L., and Cutler, G. B. Jr., daily rhythm of plasma melatonin in normal and precocious puberty. J. clin. Endocr. Metab.55 (1982) 307–310.

    PubMed  Google Scholar 

  35. Fanget, F., Claustrat, B., Dalery, J., Brun, J., Terra, J. L., Marie Cardine, M., and Guyotat, J., Nocturnal plasma melatonin levels in schizophrenic patients. Biol. Psychiatry.25 (1989) 499–501.

    PubMed  Google Scholar 

  36. Fernandes, G., Carandente, F., Halberg, E., Halberg, F., and Goog, R. A., Circadian rhythm in activity of lympholytic natural killer cells from spleens of fischer rats. J. Immun.123 (1979) 622–625.

    PubMed  Google Scholar 

  37. Fernandes, G., Halberg, H., Yunis, E. J., and Good, R. A., Circadian rhythmic plaque-forming cell response of spleens from mice immunized with SRBC. J. Immun.117 (1976) 962–966.

    PubMed  Google Scholar 

  38. Ferrier, I. N., Arendt, J., Johnstone, E. C., and Crow, T. J., Reduced nocturnal melatonin secretion in chronic schizophrenia: relationship to body weight. Clin. Endocr. (Oxford)17 (1982) 181–187.

    Google Scholar 

  39. Fevre, M., Boyar, R. M., and Rollag, M. D.. [Melatonin and LH secretion patterns in pubertal boys (author's transl)]. Ann. Endocr. (Paris.)40 (1979) 555–556.

    Google Scholar 

  40. Garratini, S., and Valzelli, L., Serotonin. Elsevier Science publishers B. V., Amsterdam 1965.

    Google Scholar 

  41. Guerrero, J. M., Prieto, J. C., Elorza, F. L., and Ramirez, R., Interaction of vasoactive intestinal peptide with blood mononuclear cells. Molec. Cell. Endocr.21 (1981) 151–160.

    PubMed  Google Scholar 

  42. Gupta, D., Riedel, L., Frick, H. J., Attanasio, A., and Ranke, M. B., Circulating melatonin in children in relation to puberty, endocrine disorders, functional tests and racial origin. Neuroendocr. Lett.5 (1983) 63–78.

    Google Scholar 

  43. Hall, N. R., and Goldstein, A. L., Neurotransmitters and the immune system, in: Psychoneuroimmunology, pp. 521–543. Ed. R. Ader. Academic Press, San Diego 1981.

    Google Scholar 

  44. Hartmann, L., Roger, M., Lemaitre, B. J., Massias, J. F., and Chaussain, J. L., Plasma and urinary melatonin in male infants during the first 12 months of life. Clin. Chim. Acta121 (1982) 37–42.

    PubMed  Google Scholar 

  45. Hastings, M. H., Neuroendocrine rhythms. Pharmac. Ther.50 (1991) 35–71.

    Google Scholar 

  46. Hellbrügge, T., Lange, J. E., Rutenfranz, J., and Stehr, K., Circadian periodicity of physiological function in different stages of infancy and childhood. Ann. N.Y. Acad. Sci.117 (1964) 361–373.

    PubMed  Google Scholar 

  47. Iguchi, H., Kato, K. I., and Ibayashi, H., Age-dependent reduction in serum melatonin concentrations in healthy human subjects. J. clin. Endocr. Metab.55 (1982) 27–29.

    PubMed  Google Scholar 

  48. Immelman, K., Role of the environment in reproduction as source of “predictive” information in: Breeding Biology of Birds, pp. 121–147 Ed. D. S. Forner. National Acadamy of Sciences, Washington D. C. 1973.

    Google Scholar 

  49. Isaacs, G., Stainer, D. S., Sensky, T. E., Moor, S., and Thompson, C., Phototherapy and its mechanisms of action in seasonal affective disorder. J. affective Disord.14 (1988) 13–19.

    Google Scholar 

  50. Jankovic, B. D., Isakovic, K., and Petrovic, S., Effect of pinealectomy on immune reactions in the rat. Immunology18 (1970) 1–6.

    PubMed  Google Scholar 

  51. Jimerson, D. C., Lynch, H. J., Post, R. M., Wurtman, R. J., and Bunney, W. E. Jr., Urinary melatonin rhythms during sleep deprivation in depressed patients and normals. Life Sci.20 (1977) 1501–1508.

    PubMed  Google Scholar 

  52. Jundell, J.. Über die nyktohermalen Temperaturschwankungen im 1. Lebensjahr des Menschen. Jb. Kinderheilk.59 (1904) 521–619.

    Google Scholar 

  53. Kasahara, T., Hooks, J. J., Dougherty, S. F., and Oppenheim, J. J. Interleukin 2-mediated immune interferon production by human T cells and T cell subsets. J. Immun.130 (1983) 1784–1789.

    PubMed  Google Scholar 

  54. Kawate, T., Hinuma, S., and Kumagi, K., Studies on the bioperiodicity of the immune response: II. Co-variations of murine T and B cells and the role of corticosteroid. J. Immun.126 (1981) 1364–1367.

    PubMed  Google Scholar 

  55. Kennaway, D. J., Stamp, G. E., and Globe, F. C., Development of melatonin production in infants and the impact of prematurity. J. clin. Endocr. Metab.75 (1992) 367–369.

    PubMed  Google Scholar 

  56. Kennedy, S. H., Tighe, S., McVey, G., and Brown, G. M., Melatonin and cortisol “switches” during mania, depression, and euthymia in a drug-free bipolar patient. J. nerv. ment. Dis.177 (1989) 300–303.

    PubMed  Google Scholar 

  57. Kitay, J. I., and Altschule, M. D., The Pineal Gland. Harvard University Press, Cambridge 1954.

    Google Scholar 

  58. Kivela, A., Serum melatonin during human pregnancy. Acta endocr. (Copenh.)124 (1991) 233–237.

    Google Scholar 

  59. Kivela, A., Kauppila, A., Leppaluoto, J., and Vakkuri, O., Serum and amniotic fluid melatonin during human labor. J. clin. Endocr. Metab.69 (1989) 1065–1068.

    PubMed  Google Scholar 

  60. Kivela, A., Kauppila, A., Leppaluoto, J., and Vakkuri, O., Melatonin in infants and mothers at delivery and in infants during the first week of life. Clin. Endocr. (Oxford)32) (1990) 593–598.

    Google Scholar 

  61. Klein, D. C., Evidence for the placental transfer of 3 H-acetyl-melatonin. Nature New Biol.237 (1972) 117–118.

    PubMed  Google Scholar 

  62. Klein, D. C., Namboordiri, M. A., and Auberbach, D. A., The melatonin rhythm generating system. Developmental aspects. Life Sci.28 (1981) 1975–1986.

    PubMed  Google Scholar 

  63. Kopin, I. J., Pare, C. M. B., Axelrod, J., and Weissbach, M., The fall of melatonin in animals. J. biol. Chem.236 (1961) 3072–3075.

    PubMed  Google Scholar 

  64. Lang, U., Beguin, P. C., and Sizonenko, P. C., Fetal and maternal melatonin concentrations at birth in humans. J. Neural. Transm. Suppl.21 (1986) 479–480.

    Google Scholar 

  65. Lang, U., Kornemark, M., Aubert, M. L., Paunier, L., and Sizonenko, P. C. Radioimmunological determination of urinary melatonin in humans: correlation with plasma levels and typical 24-hour rhythmicity. J. clin. Endocr. Metab.53 (1981) 645–650.

    PubMed  Google Scholar 

  66. Lenko, H. L., Lang, U., Aubert, M. L., Paunier, L., and Sizonenko, P. C., Hormonal changes in puberty. VII. Lack of variation of daytime plasma melatonin. J. clin. Endocr. Metab.54 (1982) 1056–1058.

    PubMed  Google Scholar 

  67. Lewy, A. J., Kern, H. E., Rosenthal, N. E., and Wehr, T. A., Bright artificial light treatment of a manic-depressive patient with a seasonal mood cycle. Am. J. Phychiat.139(11) (1982) 1496–1498.

    Google Scholar 

  68. Lewy, A. J., and Sack, R. L., The dim light melatonin onset as a marker for circadian phase position. Chronobiol. Int.6 (1989) 93–102.

    PubMed  Google Scholar 

  69. Lewy, A. J., Wehr, T. A., Gold, P. W., and Goodwin, F. K., Plasma melatonin in manic-depressive illness, in: Catecholamines: Basic and Clinical Frontiers, pp. 1173–1175. Eds E. Usdin, I. J. Kopin, and J. Barchas. Elsevier, New York 1979.

    Google Scholar 

  70. Lewy, A. J., Wehr, T. A., Goodwin, F. K., Newsome, D. A., and Markey, S. P., Light suppresses melatonin secretion in humans. Science210 (1980) 1267–1269.

    PubMed  Google Scholar 

  71. Lissoni, P., Barni, S., Crispino, S., Tancini, G., and Fraschini, F. Endocrine and immune effects of melatonin therapy in metastatic cancer patients. Eur. J. Cancer clin. Oncol.25 (1989) 789–795.

    PubMed  Google Scholar 

  72. Lissoni, P., Barni, S., Tancini, G., Crispino, S., Paolorossi, F., Cattaneo, G., Lucini, V., Mariani, M., Esposti, D., Esposti, G., and Fraschini, F., Relation between lymphocyte subpopulations and pineal function, in patients with early or metastatic cancer. Ann. N. Y. Acad. Sci.521 (1988) 290–299.

    PubMed  Google Scholar 

  73. Lissoni, P., Tisi, E., Barni, S., Ardizzoia, A., Rovelli, F., Rescaldani, R., Ballabio, D., Benenti, C., Angeli, M., Tancini, G., Conti, A., and Maestroni, G. J. M., Biological and clinical results of a neuroimmunotherapy with interleukin 2 and the pineal hormone melatonin as a first line treatment in advanced non-small cell lung cancer. Br. J. Cancer66 (1992) 155–158.

    PubMed  Google Scholar 

  74. Lissoni, P., Tisi, E., Brivio, F., Ardizzoia, A., Crispino, S., Barni, S., Tancini, G., Conti, A., and Maestroni, G. J., Modulation of interleukin-2-induced macrophage activation in cancer patients by the pineal hormone melatonin. J. biol. Regul. Homeost. Agents5 (1991) 154–156.

    PubMed  Google Scholar 

  75. Lopez-Gonzalez, M. A., Calvo, J. R., Osuna, C., Rubio, A., and Guerrero, J. M., Melatonin potentiates cyclic AMP production stimulated by vasoactive intestinal peptide in human lymphocytes. Neurosci. Lett.136 (1992) 150–152.

    PubMed  Google Scholar 

  76. Lotze, M. T., Matory, Y. L., Ettinghausen, S. E., Rayner, A. A., Sharrow, S. O., Seipp, C. A. Y., Custer, M. C., and Rosenberg, S. A., In vivo administration of purified human interleukin 2. J. Immun.135 (1985) 2865–2875.

    PubMed  Google Scholar 

  77. Lynch, H. J., Jimerson, D. C., Ozaki, Y., Post, R. M., Bunney, W. E. Jr., and Wurtman, R. J., Entrainment of rhythmic melatonin secretion in man to a 12-hour phase shift in the light/dark cycle. Life Sci.23 (1978) 1557–1563.

    PubMed  Google Scholar 

  78. Maestroni, G. J., and Conti, A., Beta-endorphin and dynorphin mimic the circadian immunoenhancing and anti-stress effects of melatonin. Int. J. Immunopharmac.11 (1989) 333–340.

    Google Scholar 

  79. Maestroni, G. J., Conti, A., and Pierpaoli, W., Role of the pineal gland in immunity. Circadian synthesis and release of melatonin modulates the antibody response and antagonizes the immunosuppressive effect of corticosterone. J. Neuroimmun.13 (1986) 19–30.

    Google Scholar 

  80. Maestroni, G. J., Conti, A., and Pierpaoli, W., Role of the pineal gland in immunity: II. Melatonin enhances the antibody response via an opiatergic mechanism. Clin. exp. Immun.68 (1987) 384–391.

    PubMed  Google Scholar 

  81. Maestroni, G. J., Conti, A., and Pierpaoli, W., Role of the pineal gland in immunity. III. Melatonin antagonizes the immunosuppressive effect of acute stress via an opiatergic mechanism. Immunology63 (1988) 465–469.

    PubMed  Google Scholar 

  82. Maestroni, G. J. M., and Conti, A., The pineal hormone melatonin stimulates activated CD4+, Thyl+, cells to release opoid agonist(s) with immunoenhancing and anti-stress properties. J. Neuroimmun.28 (1990) 167–176.

    Google Scholar 

  83. Maestroni, G. J. M., and Pierpaoli, W., Pharmacological control of the hormonally mediated immune response, in: Psychoneuroimmunology, pp. 405–428 Ed. R. Ader. Academic Press, San Diego 1981.

    Google Scholar 

  84. Mantagos, S., Koulouris, A., Makri, M., and Vagenakis, A. G., Development of thyrotropin circadian rhythm in infancy. J. clin. Endocr. Metab.74 (1992) 71–74.

    PubMed  Google Scholar 

  85. Marburg, O. Zur Kenntnis der normalen und pathologischen Histologie der Zirbeldrüse. Arb. neurol. Inst. Wien Univ.12 (1909) 217–279.

    Google Scholar 

  86. Markey, S. P., Higa, S., Shih, M., Danforth, D. N., and Tamarkin, L. The correlation between human plasma melatonin levels and urinary 6-hydroxymelatonin excretion. Clinica chim. Acta150 (1985) 221–225.

    Google Scholar 

  87. Matthews, C. D., Kennaway, D. J., Frith, R. G., Phillipou, G., LeCornu, A., and Seamark, R. F., Plasma melatonin values in man and some domestic animals: initial observations on the effects of pregnancy in many and pinealectomy in sheep. J. Endocr.73 (1977) 41P-41P.

    Google Scholar 

  88. McMillen, I. C., and Nowak, R., Maternal pinealectomy abolishes the diurnal rhythm in plasma melatonin concentrations in the fetal sheep and pregnant ewe during late gestation. J. Endocr.120 (1989) 459–464.

    PubMed  Google Scholar 

  89. Mendlewicz, J., Linkowski, P., Branchey, L., Weinberg, U., Weitzman, E. D., and Branchey, M. Abnormal 24 hour pattern of melatonin secretion in depression [letter]. Lancet2 (1979) 1362–1362.

    Google Scholar 

  90. Moller, M. The ultrastructure of the human fetal pineal gland. II Innervation and cell junctions. Cell Tissue Res.169 (1976) 7–21.

    PubMed  Google Scholar 

  91. Monteleone, P., Maj, M., Fusco, M., Kemali, D., and Reiter, R. J., Depressed nocturnal plasma melatonin levels in drug-free paranoid schizophrenics. Schizophr. Res.7 (1992) 77–82.

    PubMed  Google Scholar 

  92. Moore-Ede, M. C., Czeisler, C. A., and Richardson, G. S., Circadian timekeeping in health and disease. Part 2. Clinical implications of circadian rhythmicity. New Engl. J. Med.309 (1983) 530–536.

    PubMed  Google Scholar 

  93. Moore-Ede, M. C., Czeisler, C. A., and Richardson, G. S., Circadian timekeeping in health and disease. Part 1. Basic properties of circadian pacemakers. New Engl. J. Med.309 (1983) 469–476.

    PubMed  Google Scholar 

  94. Ogasawara, T., Adachi, N., and Nishijima, M., (Melatonin levels in maternal plasma before and during delivery, and in fetal and neonatal plasma). Nippon Sanka. Fujinka. Gakkai. Zasshi43 (1991) 335–341.

    PubMed  Google Scholar 

  95. Palazidou, E., Papadopoulos, A., Ratcliff, H., Dawling, S., and Checkley, S. A., Noradrenaline uptake inhibition increases melatonin secretion, a measure of noradrenergic neurotransmission, in depressed patients. Psychol. Med.22 (1992) 309–315.

    PubMed  Google Scholar 

  96. Pang, S. F., Melatonin concentrations in blood and pineal. Pineal Res. Rev.3 (1985) 115–160.

    Google Scholar 

  97. Pang, S. F., Tang, F., and Tang, P. L., Negative correlation of age and the levels of pineal melatonin, pineal N-acetylserotonin, and serum melatonin in male rats. J. exp. Zool.229 (1984) 41–47.

    PubMed  Google Scholar 

  98. Pang, S. F., Tang, P. L., Tang, G. W., Yam, A. W., and Ng, K. W., Plasma levels of immunoreactive melatonin, estradiol, progesterone, follicle stimulating hormone, and beta-human chorionic gonadotropin during pregnancy and shortly after parturition in humans. J. Pineal Res.4 (1987) 21–31.

    PubMed  Google Scholar 

  99. Penny, R., Melatonin excretion in normal males and females: increase during puberty. Metabolism31 (1982) 816–823.

    PubMed  Google Scholar 

  100. Penny, R., Episodic secretion of melatonin in pre- and post-pubertal girls and boys. J. clin. Endocr. Metab.60 (1985) 751–756.

    PubMed  Google Scholar 

  101. Plant, T. M., Puberty in primates, in: Physiology of Reproduction, pp. 1763–1788. Eds W. Knobil and J. Neill. Raven Press, New York 1988.

    Google Scholar 

  102. Plant, T. M., and Zorub, D. S. Pinealectomy in agonadal infantile male rhesus monkeys (Macaca mulatta) does not interrupt initiation of the prepubertal hiatus in gonadotropin secretion. Endocrinology118 (1986) 227–232.

    PubMed  Google Scholar 

  103. Poon, A. M., and Pang, S. F. 2-[125]Iodomelatonin, binding sites in spleens of guinea pigs. Life Sci.50(22) (1992) 1719–1726.

    PubMed  Google Scholar 

  104. Price, D. A., Close, G. C., and Fielding, B. A., Age of appearance of circadian rhythm in salivary cortisol values. Archs Dis. Childh.58 (1983) 454–456.

    Google Scholar 

  105. Puig-Domingo, M., Webb, S. M., and Serrano, J. Melatonin-related hypogonadotropic hypogonadism. New Engl. J. Med.327 (1992) 1356–1359.

    PubMed  Google Scholar 

  106. Reppert, S. M., and Klein, D. C., Transport of maternal (3H) melatonin to suckling rats and the fate of 3(H) melatonin in neonatal rats. Endocrinology102 (1978) 582–588.

    PubMed  Google Scholar 

  107. Robinson, S., Rosca, P., Durst, R., Shai, U., Ghinea, C., Schmidt, U., and Nir, I., Serum melatonin levels in schizophrenic and schizoaffective hospitalized patients. Acta psychiat. scand.84 (1991) 221–224.

    PubMed  Google Scholar 

  108. Rodin, A. E., and Overall, J., Statistical relationships of weight of the human pineal to age and malignancy. Cancer20 (1967) 1203–1214.

    PubMed  Google Scholar 

  109. Rosenthal, N. E., Plasma melatonin as a measure of the human clock. J. clin. Endocr. Metab.73 (1991) 225–226.

    PubMed  Google Scholar 

  110. Rosenthal, N. E., Sack, D. A. Gillin, C., Lewy, A. J., Goodwin, F. K., Davenport, Y., Mueller, P. S., Newsome, D. A., and Wehr, T. A., Seasonal affective disorder, Archs gen. Psychiat.41 (1984) 72–80.

    Google Scholar 

  111. Rosenthal, N. E., Sack, D. A., Jacobsen, F. M., James, S. P., Parry, B. L., Arendt, J., Tamarkin, L., and Wehr, T. A., Melatonin in seasonal affective disorder and phototherapy. J. Neural. Transm. Suppl.21 (1986) 257–267.

    Google Scholar 

  112. Rubin, R. T., Heist, E. K., McGeoy, S. S., Hanada, K., and Lesser, I. M., Neuroendocrine aspects of primary endogenous depression. XI. Serum melatonin measures in patients and matched control subjects. Archs gen Psychiat.49 (1992) 558–567.

    Google Scholar 

  113. Sack, R. L., and Lewy, A. J., Melatonin in major affective disorders, in: Melatonin. Clinical Perspectives, pp. 205–227. Eds A. Miles, D. R. S. Philbrick, and C. Thompson. Oxford Press, Oxford 1988.

    Google Scholar 

  114. Sack, R. L., Lewy, A. J., White, D. M., Singer, C. M., Fireman, M. J., and Vandiver, R., Morning vs evening light treatment for winter depression. Evidence that the therapeutic effects of light are mediated by circadian phase shifts. Archs gen. Pschiat.47 (1990) 343–351.

    Google Scholar 

  115. Schildkraut, J. J., The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am. J. Psychiat.122 (1965) 509–522.

    PubMed  Google Scholar 

  116. Sibinga, N. E. S., and Goldstein, A., Opioid peptides and opioid receptors in cells of the immune system. Rev. Immun.6 (1988) 219–249.

    Google Scholar 

  117. Silman, R. Melatonin and the human gonadotrophin-releasing hormone pulse generator. J. Endocr.128 (1991) 7–11.

    PubMed  Google Scholar 

  118. Smith, E. M., and Blalock, J. E., Human lymphocyte production of corticotropin and endorphin-like substances: association with leukocyte interferon. Proc. natl Acad. Sci. USA78 (1981) 7530–7534.

    PubMed  Google Scholar 

  119. Smith, E. M., and Blalock, J. E., A molecular basis for interactions between the immune and neuroendocrine systems. Int. J. Neurosci.38 (1988) 455–464.

    PubMed  Google Scholar 

  120. Smith, E. M., Harbour-McMenamin, D., and Blalock, J. E., Lymphocyte production of endorphins and endorphin-mediated immunoregulatory activity. J. Immun.135 (1985) 779s-782s.

    PubMed  Google Scholar 

  121. Smith, E. M., Phan, M., Kruger, T. E., Coppenhaver, D. H., and Blalock, J. E., Human lymphocyte production of immunoreactive thyrotropin. Proc. natl Acad. Sci. USA80 (1983) 6010–6013.

    PubMed  Google Scholar 

  122. Stanisz, A. M., Befus, D., and Bienenstock, J., Differential effects of vasoactive intestinal peptide, substance P and somatostatin on immunoglobulin synthesis and proliferation by lymphocytes from Peyer's plaques, mesenteric lymph nodes and spleen. J. Immun.136 (1986) 152–156.

    PubMed  Google Scholar 

  123. Tamarkin, L., Abastillas, P., Chen, H. C., McNemar, A., and Sidbury, J. B., The daily profile of plasma melatonin in obese and Prader-Willi syndrome children. J. clin. Endocr. Metab.55 (1982) 491–495.

    PubMed  Google Scholar 

  124. Tamarkin, L., Baird, C. J., and Almeida, O. F., Melatonin: a coordinating signal for mammalian reproduction. Science227 (1985) 714–720.

    PubMed  Google Scholar 

  125. Tetsuo, M., Poth, M., and Markey, S. P., Melatonin metabolite excretion during childhood and puberty. J. clin. Endocr. Metab.55 (1982) 311–313.

    PubMed  Google Scholar 

  126. Thompson, C., Melatonin and seasonal affective disorder, in: Melatonin. Clinical Perspectives, pp. 228–242. Eds A. Miles, D. R. S. Philbrick and C. Thompson. Oxford Press, Oxford 1988.

    Google Scholar 

  127. Thompson, C., Franey, C., Arendt, J., and Checkley, S. A., A comparison of melatonin secretonin in depressed patients and normal subjects. Br. J. Psychiat.152 (1988) 260–265.

    Google Scholar 

  128. Touitou, Y., Fevre, M., Lagoguey, M., Carayon, A., Bogdan, A., Reinberg, A., Beck, H., Cesselin, F., and Touitou, C, Age-and mental health-related circadian rhythms of plasma levels of melatonin, prolactin, luteinizing hormone and follicle-stimulating hormone in man. J. Endocr.91 (1981) 467–475.

    PubMed  Google Scholar 

  129. Utiger, R. D., Melatonin — the hormone of darkness. New Engl. J. Med.327 (1992) 1377–1379.

    PubMed  Google Scholar 

  130. Vener, K. J., Szabo, S., and Moore, J. G., The effect of shift work on gastrointestinal (GI) function: a review. Chronobiologia16 (1989) 421–439.

    PubMed  Google Scholar 

  131. Vicente, P., Garcia, A., Alvarez, E., Clemente, S., and Blazquez, E., Presence of melatonin in the umbilical cord blood of full-term human newborns. J. Pineal Res.6 (1989) 135–140.

    PubMed  Google Scholar 

  132. Waldhauser, F., Boepple, P., and Crowley, W. F. Jr., Changes of serum melatonin levels during sexual maturation. (1993) in press.

  133. Waldhauser, F., Boepple, P. A., Schemper, M., Mansfield, M. F., and Crowley, W. F. Jr., Serum melatonin in central precocious puberty is lower than in age-matched prepubertal children. J. clin. Endocr. Metab.73 (1991) 793–796.

    PubMed  Google Scholar 

  134. Waldhauser, F., and Dietzel, M., Daily and annual rhythms in human melatonin secretion: role in puberty control. Ann. N. Y. Acad. Sci.453 (1985) 205–214.

    PubMed  Google Scholar 

  135. Waldhauser, F., and Gisinger, B., The pineal gland and its development in human puberty, in: The Pineal Gland during Development: From Fetus to Adult, pp. 134–143. Eds D. Gupta, and R. J. Reiter. Croom Helm Ltd., London 1986.

    Google Scholar 

  136. Waldhauser, F., and Trinchard-Lugan, I., Age-related alterations of human serum melatonin. in: Fundamentals and Clinics in Pineal Research, pp. 369–376. Eds G. P. Trentini, C. De Gaetani and P. Pevet, Raven Press, New York 1987.

    Google Scholar 

  137. Waldhauser, F., and Waldhauser, M., Melatonin and ageing, in: Melatonin-Clinical Perspectives, pp. 174–189. Eds A. Miles, D. R. S. Philbrick and C. Thompson. Oxford University Press, Oxford 1988.

    Google Scholar 

  138. Waldhauser, F., Weiszenbacher, G., Frisch, H., Zeilhuber, U., Waldhauser, M., and Wurtman, R. J., Fall in nocturnal serum melatonin during prepuberty and pubescence. Lancet1 (1984) 362–365.

    PubMed  Google Scholar 

  139. Waldhauser, F., Weiszenbacher, G., Tatzer, E., Gisinger, B., Waldhauser, M., Schemper, M., and Frisch, H., Alterations in noctural serum melatonin levels in human with growth and aging. J. clin. Endocr. Metab.66 (1988) 648–652.

    PubMed  Google Scholar 

  140. Waterman, G. S., Ryan, N. D., Perel, J. M., Dahl, R. E., Birmaher, B., Williamson, D. E., Thomas, C. R., and Puig-Antich, J., Nocturnal urinary excretion of 6-hydroxymelatonin sulfate in prepubertal major depressive disorder. Biol. Psychiat.31 (1992) 582–590.

    PubMed  Google Scholar 

  141. Wehr, T. A., Jacobsen, F. M., Sack, D. A., Arendt, J., Tamarkin, L., and Rosenthal, N. E., Phototherapy of seasonal affective disorder. Time of day and suppression of melatonin are not critical for antidepressant effects. Archs gen. Psychiat.43 (1986) 870–875.

    Google Scholar 

  142. Wehr, T. A., Wirz-Justice, A., Goodwin, F., Duncan, W., and Gillin, J. C., Phase advance of the circadian sleep-wake cycle as an antidepressant. Science206 (1979) 710–713.

    PubMed  Google Scholar 

  143. Wetterberg, L., Aperia, B., Beck Friis, J., Kjellman, B. F., Ljunggren, J. G., Nilsonne, A., Petterson, U., Tham, A., and Unden, F., Melatonin and cortisol levels in psychiatric illness [letter]. Lancet2 (1982) 100.

    Google Scholar 

  144. Wetterberg, L., Beck Friis, J., Aperia, B., and Peterson, U., Melatonin/cortisol ratio in depression [letter]. Lancet2 (1979) 1361.

    Google Scholar 

  145. Wetterberg, L., Beck Friis, J., Kjellman, B. F., and Ljunggren, J. G. Circadian rhythms in melatonin and cortisol secretion in depression. Adv. Biochem. Psychopharmac39 (1984) 197–205.

    Google Scholar 

  146. Wirz-Justice, A., and Arendt, J., Plasma melatonin and antidepressant drugs [letter]. Lancet1 (1980) 425.

    Google Scholar 

  147. Wurtman, R. J., Axelrod, J., and Barchas, J. D., Age and enzyme activity in the human pineal gland. Endocrinology24 (1964) 299–301.

    Google Scholar 

  148. Yellon, S. M., and Longo, L. D., Effect of maternal pinealectomy and reverse photoperiod on the circadian melatonin rhythm in the sheep and fetus during the last trimester of pregnancy. Biol. Reprod.39 (1988) 1093–1099.

    PubMed  Google Scholar 

  149. Young, I. M., Francis, P. L., Leone, A. M., Stovell, P., and Silman, R. E., Constant pineal output and increasing body mass account for declining melatonin levels during human growth and sexual maturation. J. Pineal Res.5 (1988) 71–85.

    PubMed  Google Scholar 

  150. Yu, Z. H., Yuan, H., Lu, Y., and Pang, S. F., [125] Iodomelatonin binding sites in spleens of birds and mammals. Neurosci. Lett.125(2) (1991) 175–178.

    PubMed  Google Scholar 

  151. Zemdegs, I. Z., McMillen, I. C., Walker, D. W., Thorburn, G. D., and Nowak, R., Diurnal rhythms in plasma melatonin concentrations in the fetal sheep and pregnant ewe during late gestation. Endocrinology123 (1988) 284–289.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, University of Vienna, Wàhringer Gùrtel 18-20, A-1090, Vienna, (Austria)

    F. Waldhauser, B. Ehrhart & E. Förster

Authors
  1. F. Waldhauser
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. Ehrhart
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. Förster
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Waldhauser, F., Ehrhart, B. & Förster, E. Clinical aspects of the melatonin action: impact of development, aging, and puberty, involvement of melatonin in psychiatric disease and importance of neuroimmunoendocrine interactions. Experientia 49, 671–681 (1993). https://doi.org/10.1007/BF01923949

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01923949

Key words

Search

Navigation